Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Galaxia M Rodriguez

6PUBLICATIONS

19CO-AUTHORS

Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Tumour immunology

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (6)

Sort by Publication Date:

|Apr 12, 2025

Loss of LATS1 and LATS2 promotes ovarian tumor formation by enhancing AKT activity and PD-L1 expression.

Yalun Zhu, Atefeh Abedini, Galaxia M Rodriguez

|Mar 10, 2025

Specific Genetic Mutations Impact Chemotherapy Resistance and Therapeutic Efficacy of Oncolytic Viruses in Ovarian Cancer.

Alison O Cudmore, Galaxia M Rodriguez, Vincent Maranda

|Dec 09, 2023

Unveiling the Immunogenicity of Ovarian Tumors as the Crucial Catalyst for Therapeutic Success.

Galaxia M Rodriguez, Edward Yakubovich, Barbara C Vanderhyden

|Aug 26, 2023

Conventional DNA-Damaging Cancer Therapies and Emerging cGAS-STING Activation: A Review and Perspectives Regarding Immunotherapeutic Potential.

Jordan D Lewicky, Alexandrine L Martel, Mukul Raj Gupta

|Jul 28, 2018

Ovarian Cancer Immunotherapy: Preclinical Models and Emerging Therapeutics.

Curtis W McCloskey, Galaxia M Rodriguez, Kristianne J C Galpin

|Jul 26, 2018

The Tumor Microenvironment of Epithelial Ovarian Cancer and Its Influence on Response to Immunotherapy.

Galaxia M Rodriguez, Kristianne J C Galpin, Curtis W McCloskey

Pageof 1

Frequent Collaborators

6 joint publications

Barbara Vanderhyden

2 joint publications

Kristianne J C Galpin

2 joint publications

Curtis W McCloskey

1 joint publications

Alexandrine L Martel

1 joint publications

René Roy

1 joint publications

Hoang-Thanh Le

1 joint publications

Edward Yakubovich

1 joint publications

Alison O Cudmore

1 joint publications

Vincent Maranda

1 joint publications

Salar Farokhi Boroujeni

Frequent Collaborators

6 joint publications

Barbara Vanderhyden

2 joint publications

Kristianne J C Galpin

2 joint publications

Curtis W McCloskey

1 joint publications

Alexandrine L Martel

Top Related Videos

Utilizing <sup>18</sup>F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Utilizing <sup>18</sup>F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Published on : Jul 21, 2018

Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy

Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy

Published on : Apr 03, 2018

An Orthotopic Model of Serous Ovarian Cancer in Immunocompetent Mice for <em>in vivo</em> Tumor Imaging and Monitoring of Tumor Immune Responses

An Orthotopic Model of Serous Ovarian Cancer in Immunocompetent Mice for <em>in vivo</em> Tumor Imaging and Monitoring of Tumor Immune Responses

Published on : Nov 28, 2010

See more related videos

Top Related Videos

Utilizing <sup>18</sup>F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Utilizing <sup>18</sup>F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Published on : Jul 21, 2018

Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy

Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy

Published on : Apr 03, 2018

An Orthotopic Model of Serous Ovarian Cancer in Immunocompetent Mice for <em>in vivo</em> Tumor Imaging and Monitoring of Tumor Immune Responses

An Orthotopic Model of Serous Ovarian Cancer in Immunocompetent Mice for <em>in vivo</em> Tumor Imaging and Monitoring of Tumor Immune Responses

Published on : Nov 28, 2010

See more related videos